Saffron: A potential candidate for a novel anticancer drug against hepatocellular carcinoma

Hepatology

Volumn 54, Issue 3, 2011, Pages 857-867

  Amin, Amr ^a,c   Hamza, Alaaeldin A ^a   Bajbouj, Khuloud ^a   Ashraf, S Salman ^a   Daoud, Sayel ^b  

^a UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

^b TAWAM HOSPITAL   (United Arab Emirates)

^c CAIRO UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA FETOPROTEIN; ANTINEOPLASTIC AGENT; ANTIOXIDANT; CARBONYL DERIVATIVE; CASPASE 3; CATALASE; CYCLOOXYGENASE 2; DIETHYLNITROSAMINE; DNA NUCLEOTIDYLEXOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; GLUTATHIONE TRANSFERASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; KI 67 ANTIGEN; MALONALDEHYDE; MYELOPEROXIDASE; SAFFRON; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CANCER INCIDENCE; CANCER INHIBITION; CELL CYCLE ARREST; CELL DIVISION; CELL STRAIN HEPG2; CHEMOPROPHYLAXIS; CONTROLLED STUDY; CYTOTOXICITY; DNA DAMAGE; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; IN VITRO STUDY; IN VIVO STUDY; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER FUNCTION; LIVER PROTECTION; LOW DRUG DOSE; MALE; NICK END LABELING; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN CARBONYLATION; RAT;

ANIMALS; ANTIOXIDANTS; APOPTOSIS; CELL PROLIFERATION; CROCUS; CYCLOOXYGENASE 2; DIETHYLNITROSAMINE; GLUTATHIONE TRANSFERASE; HEP G2 CELLS; HUMANS; LIVER; LIVER NEOPLASMS, EXPERIMENTAL; NITRIC OXIDE SYNTHASE TYPE II; PHYTOTHERAPY; PLANT EXTRACTS; RATS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 80052033921     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.24433     Document Type: Article

References (27)

1. Park DH, Shin JW, Park SK, Seo JN, Li L, Jang JJ, et al. Diethylnitrosamine (DEN) induces irreversible hepatocellular carcinogenesis through overexpression of G1/S-phase regulatory proteins in rat. Toxicol Lett 2009; 191: 321-326.
2. Li X, Zhou XP, Guan YS, Wang YX. Magnetic resonance imaging of hepatocellular carcinoma induced by diethylnitrosamine in Sprague-Dawley rats. Hepatobiliary Pancreat Dis Int 2005; 4: 427-432.
3. Hodek P, Krízková J, Burdová K, Sulc M, Kizek R, Hudecek J, et al. Chemopreventive compounds---view from the other side. Chem Biol Interact 2009; 180: 1-9.
4. Abdullaev FI, Espinosa-Aguirre JJ. Biomedical properties of saffron and its potential use in cancer therapy and chemoprevention trials. Cancer Detect Prev 2004; 28: 426-432.
5. Abdullaev FI. Cancer chemopreventive and tumoricidal properties of saffron (Crocus sativus L.). Exp Biol Med (Maywood) 2001; 227: 20-25.
6. Das I, Das S, Saha T. Saffron suppresses oxidative stress in DMBA-induced skin carcinoma: A histopathological study. Acta Histochem 2010; 112: 317-327.
7. Espandiari P, Robertson LW, Srinivasan C, Glauert HP. Comparison of different initiation protocols in the resistant hepatocyte model. Toxicology 2005; 206: 373-381.
8. Hosseinzadeh H, Younesi HM. Antinociceptive and anti-inflammatory effects of Crocus sativus L. stigma and petal extracts in mice. BMC Pharmacol 2002; 2: 1-8.
9. Tai W, Hu T, Wang J, Hung C, Lu S, Changchien C, et al. Clinical implications of alpha-fetoprotein in chronic hepatitis C. J Formos Med Assoc 2009; 108: 210-218.
10. Uchiyama M, Mihara M. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal Biochem 1978; 86: 271-278.
11. Reznick AZ, Packer L. Oxidative damage to proteins: spectrophotometric method for carbonyl assay. Methods Enzymol 1994; 233: 357-363.
12. Hillegass LM, Griswold DE, Brickson B, Albrightson-Winslow C. Assessment of myloperoxidase activity in whole rat kidney. J Pharmacol Methods 1990; 24: 285-295.
13. Aebi H. Catalase in vitro. Methods Enzymol 1984; 105: 121-126.
14. Nandi A, Chatterjee IB. Assay of superoxide dismutase activity in animal tissues. J Biosci 1988; 13: 305-315.
15. Van Dooran R, Leijdekkers CM, Henderson PT. Synergistic effects of phorone on the hepatotoxicity of bromobenzene and paracetamol in mice. Toxicology 1978; 11: 225-233.
16. Habig WH, Pabst MJ, Jakoby WB. Glutathione-S-transferases. The first enzymatic step in mercapturic acid formation. J Biol Chem 1974; 249: 7130-7139.
17. Peterson GL. A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal Biochem 1977; 83: 346-356.
18. Scholzen T, Gerdes J. The Ki-67 protein: From the known and unknown. J Cell Physiol 2000; 182: 311-322.
19. Eriksson L, Ahluwalia M, Spiewak J, Lee G, Sarma DSR, Roomi MJ, et al. Distinctive biochemical pattern associated with resistance hepatocytes in hepatocyte nodules during liver carcinogenesis. Environ Health Perspect 1983; 49: 171-174.
20. Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 2006; 160: 1-40.
21. Reuter S, Gupta SC, Chaturvedi MM, Aggarwal BB. Oxidative stress, inflammation, and cancer: How are they linked. Free Radic Biol Med 2010; 49: 1603-1616.
22. Aung HH, Wang CZ, Ni M, Fishbein A, Mehendale SR, Xie JT, et al. Crocin from crocus sativus possesses significant anti-proliferation effects on human colorectal cancer cells. Exp Oncol 2007; 29: 175-180.
23. Karimi E, Oskoueian E, Hendra R, Jaafar HZ. Evaluation of Crocus sativus L. stigma phenolic and flavonoid compounds and its antioxidant activity. Molecules 2010; 15: 6244-6256.
24. Kundu JK, Surh YJ. Breaking the relay in deregulated cellular signal transduction as a rationale for chemoprevention with anti-inflammatory phytochemicals. Mutat Res 2005; 591: 123-146.
25. Loria V, Dato I, Graziani F, Biasucci LM. Myloperoxidase: A new biomarker of inflammation in ischemic heart disease and acute coronary syndromes. Mediators Inflamm 2008; 2008: 135625.
26. Karin M, Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-kB activity. Annu Rev Immunol 2008; 18: 621-663.
27. Surh YJ, Chun KS, Cha HH, Han SS, Keum YS, Park KK, et al. Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kB activation. Mutat Res 2001; 480-481: 243-268.